Hon Speaker, I move without notice:
That the House -
(1) notes that the first clinical trial of an HIV/Aids vaccine designed and developed in South Africa to determine the immune response of HIV subtype C under way in this country and in the United States of America, has shown good results and will assist scientists in their goal of creating a vaccine to combat Aids;
(2) acknowledges accolades from the US National Institute of Allergy and Infectious Diseases, that South Africa has "some of the finest scientists in the world";
(3) further acknowledges that the vast majority of scientists referred to in this are women;
(4) congratulates sister Professors Anna-Lise and Caroline Williamson, leaders of the vaccine development team, and all scientists involved in this work at the University of Cape Town; and
(5) also congratulates Professor Glenda Gray and her clinical trials team in Johannesburg whose work will positively impact on the designing and manufacturing of vaccines against other infectious diseases such as new strains of HIV; A/H1N1, or swine flu, and H5N1 influenza, or avian flu, which are causing much suffering globally at this time.
Agreed to.